Development of a yeast assay for rapid screening of inhibitors of human-derived Pneumocystis carinii dihydrofolate reductase.

Antimicrob Agents Chemother

Critical Care Medicine Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland 20892-1662, USA.

Published: September 2002

Human-derived Pneumocystis carinii dihydrofolate reductase (DHFR) was expressed in a Saccharomyces cerevisiae strain whose growth depends on complementation by this enzyme. We utilized a quantitative assay to measure the sensitivity of this yeast strain to DHFR inhibitors. This assay should be useful for identifying new inhibitors of human-derived P. carinii DHFR.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC127411PMC
http://dx.doi.org/10.1128/AAC.46.9.3101-3103.2002DOI Listing

Publication Analysis

Top Keywords

inhibitors human-derived
8
human-derived pneumocystis
8
pneumocystis carinii
8
carinii dihydrofolate
8
dihydrofolate reductase
8
development yeast
4
yeast assay
4
assay rapid
4
rapid screening
4
screening inhibitors
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!